FDA issues long-overdue alert on popular gout med

It’s an urgent warning that took the FDA years to issue… and it’s not done yet!

From the start — practically a decade ago during clinical trials — it was quite obvious that the gout med Uloric was linked to heart attacks, strokes, and other “heart-related” deaths.

But the FDA went ahead and approved it anyway.

That was in 2009! And now, that decision is coming back to haunt us.

It seems that patients who take Uloric (which also goes by the generic name of febuxostat) are at a much bigger risk of dying than those prescribed another med for gout.

And when you consider that the other drug is also known to produce horrible side effects, it should give you an idea of just how bad Uloric is!

So, if you or someone you love suffers from the toe-stabbing pain of gout, steering clear of these incredibly risky drugs should be first on your list — especially since there are natural, nontoxic remedies that have been long proven to work wonders for this painful condition.


Too little, too late

Anyone who suffers from the excruciating pain of gout is at risk of a double whammy.

They not only have to deal with the condition itself, described as being “the most agonizing joint pain” there is… but the drugs doctors prescribe for it are some of the most dangerous ones on the market.

When the FDA first OK’d Uloric, the subject of this new alert, the agency knew about the heart risk. But, true to form, the FDA gave it the green light to go out the door, with only one caveat: Takeda Pharmaceuticals, the manufacturer, would be required to conduct (albeit belated) safety studies.

You know the kind — one of those “approve-first, ask-questions-later” kind of deals.

Well, that study is now complete, and the danger this drug poses to your heart is so apparent that the FDA had to rush to issue an immediate “safety announcement” — and the final results aren’t even in yet!

This wasn’t some little study, either, but one that looked at over 6,000 patients.

Interestingly, the research didn’t show that increased risk when taken “as a whole” — it wasn’t until the individual outcomes were teased apart that the heart danger became obvious.

That just goes to show how Big Pharma can so easily manipulate data such as this to claim that a drug is safe… when that’s far from the case.

As I mentioned, this study compared Uloric with another gout med, called allopurinol (sold under the brand names of Zyloprim and Aloprim). But while Uloric might have caused more deadly heart problems (as well as additional deaths from all causes), that second drug is no walk in the park, either.

Last year, we warned you how allopurinol was found in a multinational study to be commonly associated with a horrific condition called Stevens-Johnson syndrome, something that can literally cause your skin to peel off of your body as if you were being boiled alive.

Along with that, the label for allopurinol warns that it’s “not an innocuous drug.”

If that doesn’t make you think twice about talking it, I don’t know what would!

Certainly, gout is a painful and disabling condition. But that doesn’t mean treating it should put you at risk of having your skin peel off or suffering a fatal heart attack or stroke.

Especially when there are safe and proven uric acid-busters available, such as:

  • Cherry juice, the benefits of which aren’t just some old wives’ tale, but have been known to alleviate gout symptoms since 1950! You can take either a daily dose of a cup of tart cherry juice (twice a day) or a daily cherry extract supplement.
  • Apple cider vinegar, with a tablespoon or two in a glass of water sipped during the day being all you need to lower uric acid buildup.
  • Vitamin C, which can significantly reduce uric acid and your risk of gout when you take just 1,500 mg a day.

And one thing you want to be sure to keep as low as possible is anything that contains fructose, especially in the form of HFCS, agave syrup, crystalline fructose, or even sugar, as that will quickly raise your uric acid levels.

“FDA Drug Safety Communication: FDA to evaluate increased risk of heart-related death and death from all causes with the gout medicine febuxostat (Uloric)” FDA, November 15, 2017, fda.gov